Spinal and extracranial metastatic dissemination of malignant glioma
Journal of Clinical Neuroscience, ISSN: 0967-5868, Vol: 12, Issue: 4, Page: 379-382
2005
- 27Citations
- 17Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations27
- Citation Indexes27
- 27
- CrossRef22
- Captures17
- Readers17
- 17
Article Description
Metastatic dissemination of malignant glioma is rare. Metastatic disease usually occurs within the neuraxis but extracranial spread to the liver, spleen, lung, peritoneum and lymph nodes can also occur. In most cases of metastatic disease, the patient has previously undergone a craniotomy. The prognosis is uniformly poor. The vast majority of patients do not survive beyond six months from diagnosis of metastatic spread of a primary intracranial tumour. The pathophysiology and natural history of this condition is still not fully understood, hence well-designed prospective studies are needed.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0967586805000020; http://dx.doi.org/10.1016/j.jocn.2004.11.004; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=19744371067&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/15925766; https://linkinghub.elsevier.com/retrieve/pii/S0967586805000020; https://dx.doi.org/10.1016/j.jocn.2004.11.004
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know